The present study aimed to evaluate the effectiveness of ozone therapy compared to conventional treatment in the postsurgical management of incisions in cancer patients undergoing radical mastectomy, radical prostate, ctomy and breast-conserving surgery.
The approach was mixed, quantitative-qualitative, prospective and longitudinal. The sample consisted of 50 patients, randomly distributed into two groups: an intervention group (n=25) with ozone therapy and conventional treatment, and a control group (n=25) with exclusive traditional therapy. Five clinical indicators were evaluated: time to complete epithelialization, incisional infection, edema, pain, and suture dehiscence. The results demonstrated a significant superiority of group 1 treated with ozone therapy. This group had a more rapid epithelialization, without cases of infection or dehiscence, and with evident clinical reductions in pain and edema. In contrast, the control group recorded complications such as incision infection (4 cases), suture dehiscence (6 cases), and persistence of inflammation and pain in several patients. Ozone therapy was applied systemically (autohemotherapy), rectal and topical with BODYOZONE, following personalized protocols according to the type of surgery. The research concludes that O?T is an effective complementary intervention, safe in the postsurgical oncological context. Its antimicrobial, anti-inflammatory and regenerative effect significantly improve recovery times and reduces postoperative complications, providing considerable clinical value to the comprehensive management of cancer patients. Its implementation in specialized centers and long-term follow-up studies are recommended.
